PATENT CLAIM ANALYSIS

Application Number: 15754649
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-09
Patent Classification: ["514", "293000"]

Abstract:
The present disclosure pertains to a pharmaceutical combination comprising (a) alpha-isoform specific PI3K inhibitor and (b) an AKT inhibitor; combined preparations and pharmaceutical compositions thereof; the uses of such combination in the treatment or prevention of cancer; and methods of treating or preventing cancer in a subject in need thereof comprising administering a therapeutically effective amount of such combination.

Claim (Index 34):
A pharmaceutical combination comprising:\n (a) a compound having the structure of Formula (I) or a pharmaceutically acceptable salt thereof, and (b) an AKT inhibitor.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 88.0
- Lexical Diversity: 1.55814
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15755140', '15755122', '14240499', '13799076', '14419256']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7536540288999984
- 35 USC 102 Novelty (BERT): 0.5402709482313144
- Combined Prediction Score: 0.73231572083313
- Mean Citation Score: 326.0346760000001
- Max Citation Score: 369.83292
- Similarity Product: 249.6253879097271

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test